A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...

Astatine-211 (At-211) is an isotope gaining significant attention in medical research, potentially offering a revolution in how cancer is treated. It is known as the rarest naturally occurring element ...

Astatine is the rarest naturally occurring element on Earth and among the least explored in the periodic table. True to its Greek name meaning "unstable," it exists only fleetingly in nature. Yet ...

The companies have a seed portfolio of 128MW of electricity generation assets. Image: Aviva Investors. Aviva Investors, the investment arm of insurance provider Aviva, and Irish renewable energy ...

Aviva Investors has partnered with Irish renewable energy infrastructure firm Astatine on an €800 million energy transition platform. The partnership is aimed at creating a single platform to fund and ...

The platform will fund energy infrastructure projects in Ireland, the UK and across Europe. Aviva Investors, which is the global asset management business of Aviva plc, has announced a partnership ...

NAYA's Lead Astatine-211 Targeted Alpha Therapy, NY-703, Aiming to Enter Clinical Trials for Residual & Metastatic HCC in 2026 MIAMI, FL and LANSING, MI / ACCESS Newswire / August 21, 2025 / NAYA ...

A big summer movie premiere coupled with promotional video games, just like the old days. A big summer movie premiere coupled with promotional video games, just like the old days. is an entertainment ...

CHESTER SPRINGS, Pa., July 23, 2025 /PRNewswire/ -- Curadh MTR Inc. ("Curadh") and Alpha Fusion, Inc. ("Alpha Fusion") will present on the clinical development of radiopharmaceutical products at the ...

A team at Texas A&M University has developed an automated system for separating and shipping At-211. This patent-pending device enables the radioisotope to be purified and loaded as part of the ...